mark w lowdell
Royal Free London NHS Foundation Trust
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
Royal Free London NHS Foundation Trust
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
Tianjin University
Tianjin, China
Associate Editor
Cancer Immunity and Immunotherapy
University of Arkansas for Medical Sciences
Little Rock, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Oviedo
Oviedo, Spain
Associate Editor
Cancer Immunity and Immunotherapy
University of TĂĽbingen
TĂĽbingen, Germany
Associate Editor
Cancer Immunity and Immunotherapy
Center of Systems Medicine, Chinese Academy of Medical Sciences, Suzhou Institute of Systems Medicine (ISM)
Suzhou, China
Associate Editor
Cancer Immunity and Immunotherapy
Medical College of Wisconsin
Milwaukee, United States
Associate Editor
Cancer Immunity and Immunotherapy
CNRS
Lille, France
Associate Editor
Cancer Immunity and Immunotherapy
University of California, San Diego
La Jolla, United States
Associate Editor
Cancer Immunity and Immunotherapy
Champalimaud Centre for the Unknown, Champalimaud Foundation
Lisboa, Portugal
Associate Editor
Cancer Immunity and Immunotherapy
Washington University in St. Louis
St. Louis, United States
Associate Editor
Cancer Immunity and Immunotherapy
King's College London
London, United Kingdom
Associate Editor
Cancer Immunity and Immunotherapy
Faculty of Pharmaceutical Sciences, UCSI University
Kuala Lumpur, Malaysia
Associate Editor
Cancer Immunity and Immunotherapy
Medical College of Wisconsin
Milwaukee, United States
Associate Editor
Cancer Immunity and Immunotherapy
University of Turin
Turin, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University of Padua
Padua, Italy
Associate Editor
Cancer Immunity and Immunotherapy